CHRISTINE CALMA: Open Payments
NPI 1821051350 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 33 payments from 15 companies in 2025. Trend: 2023 $220 · 2024 $499 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $173 |
| Abbott Laboratories | 5 | $108 |
| Lilly USA, LLC | 4 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73 |
| Novo Nordisk Inc | 4 | $72 |
| Amgen Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
Products named: SAPIEN 3 Ultra RESILIA, MOUNJARO, FREESTYLE LIBRE 3, JARDIANCE, EVENITY, BEXSERO, UBRELVY, TZIELD.
Industry payments across CA — which companies pay providers there.
